RCMU
AMGN icon

Rokos Capital Management (UK)’s Amgen AMGN Stock Holding History

Rokos Capital Management (UK)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,500
Closed -$4.29M – 6
2019
Q1 		$4.29M Buy
+22,500
New +$4.3M 3.53% 9

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rokos Capital Management (UK)'s AMGN Position: Q2 2019 in Review

Rokos Capital Management (UK) sold out of Amgen (AMGN) in Q2 2019, closing a stake of 850 shares — an estimated $162K sold.

Rokos Capital Management (UK) first reported a position in AMGN in Q1 2019 and held it in 1 quarter. The position peaked at $162K in Q1 2019. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Rokos Capital Management (UK) reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 850 Amgen shares in Q2 2019, an estimated $162K.
  • Rokos Capital Management (UK) first reported a position in Amgen in Q1 2019 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s Amgen position peaked at $162K in Q1 2019.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Rokos Capital Management (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.